Discover PharmExtracta’s groundbreaking achievements! Two of our products, Crispact® and Sophy®, are finalists at NutraIngredients Awards Europe 2024.
Join us at Vitafoods, stand Q90, to witness how Crispact® and Sophy® revolutionize women’s well-being. Don’t miss the chance to explore our innovative solutions: mark your calendars and visit our booth to learn more.
Chasteberry extract, recognized by the EMA since 2010, is a potent ally against menstrual disorders and PMS, targeting prolactin and progesterone levels.
A recent study examined MonoSelect® Agnus in managing PMS, showcasing significant symptom reduction, especially with continuous usage, offering a promising treatment avenue.
To address Genitourinary Syndrome of Menopause (GSM), PharmExtracta developed Zantogin® vaginal gel, a patented medical device containing highly purified plant extracts and hyaluronic acid to provide healing, re-epithelizing, and moisturizing effects.
A recent study conducted at Sapienza University of Rome demonstrates the positive impact of Zantogin® Gel on post-menopausal women suffering from GSM. Study results show not only a significant improvement in GSM symptoms but also a remarkable decrease in dyspareunia and improvements in the Vaginal Health Index, Female Sexual Distress Scale, and Regular Sexual Activity.
Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent and potentially serious condition affecting millions worldwide. Often diagnosed alongside lifestyle recommendations, it is crucial to explore alternative interventions to improve liver health and prevent the progression of the disease.
Hepa G®, with its unique formulation and patent protection, emerges as a promising solution to enhance liver health, offering new hope and possibilities for individuals facing the challenges of NAFLD.
Antibiotics remain a fundamental tool crucial for saving lives. However, their overuse or misuse can adversely affect the gut microbiota, leading to both short-term and long-term consequences.
Brevicillin® is a novel probiotic that features the strain Bifidobacterium breve PRL2020, specifically identified to mitigate the detrimental effects of therapies involving amoxicillin and amoxicillin/clavulanic acid. The unique intrinsic resistance to these antibiotics of Bifidobacterium breve PRL2020 ensures a completely safe profile.
Over 40% of patients suffering from Gastroesophageal Reflux Disease still grapple with symptoms despite relying on proton pump inhibitors (PPIs). A dedicated review explores advanced therapies to support them, unveiling Mirgeal® gel as a revolutionary adjunctive treatment.
With unique ingredients like licorice extract and Mirtoselect®, Mirgeal® gel outperforms traditional options, providing lasting relief and transforming GERD care.
PCOS poses challenges affecting various aspects of women’s lives, often hindered by limited treatment options and side effects from conventional therapies.
Sophy® addresses these issues by harnessing Berberine’s potential, with the innovative Berberine Phytosome® that enhances absorption, making Berberine 10 TIMES MORE bioavailable.
A recent clinical trial demonstrated remarkable results in just 3 months, including an 80% decrease in menstrual disorders, a 70% decrease in ovarian polycystosis, and a 55% decrease in acne.
The rise in infertility rates has prompted the growth of ART procedures. A recent study assesses the potential role of Crispact® with Lactobacillus crispatus M247 in enhancing the success of ART for 160 infertile women undergoing various procedures.
Results in treated women show a 36% increase in positive pregnancy tests, 88% in D5 embryo transfers, and 67% more live births compared to the control group. These promising outcomes undoubtedly open up dialogue on Crispact®‘s role in fertility treatments.
According to science, the benefits of Nigella sativa include anti-inflammatory, antioxidant, immune support, and more. However, when choosing a supplement based on this botanical, Thymoquinone concentration is crucial.
Nisatol® maximizes the potential of Nigella Sativa with a 10% Thymoquinone content. Furthermore, its unique formulation ensures optimal absorption, featuring enteric coating and Vitamin E to guard against oxidation.
Research shows that berberine with silymarin has better absorption than berberine alone. A 2018 meta-analysis focused specifically on studies examining this combination, and after evaluating 26 studies, only 5 studies on Berberol® were found to be eligible.
Berberol® is the most studied product containing a fixed combination of berberine and silymarin, which enables a much better absorption of berberine and unlocks its impressive potential to improve metabolic parameters.